BILIO 发表于 2025-3-26 22:14:33
Robson Augusto Souza SantosThe first book addressing in full the most important aspects of Angiotensin-(1-7).An integrative view of the modulatory biological actions of Ang-(1-7) within the renin-angiotensin system.Discusses thinterrogate 发表于 2025-3-27 02:39:51
http://image.papertrans.cn/a/image/157441.jpg要塞 发表于 2025-3-27 06:27:31
http://reply.papertrans.cn/16/1575/157441/157441_33.pngHARD 发表于 2025-3-27 09:49:35
Tools for Studying Angiotensin-(1-7)There are many genetic and pharmacological tools available for the study of the pharmacological and pathophysiological implications of angiotensin-(-1-7). In this chapter, we address the pharmacological tools for interfering with the formation and actions of this heptapeptide.大洪水 发表于 2025-3-27 17:10:07
The Angiotensin-(1-7) Axis: Formation and Metabolism Pathways, that opposes many actions of the Ang II-AT.R axis. In lieu of the complexity of this system, the chapter discusses the current evidence on the enzymatic cascade of the Ang-(1-7) axis of the RAS regarding the peptidases that contribute to the formation and degradation of the peptide in the circulatiagonist 发表于 2025-3-27 18:58:56
Heart – Coronary Vessels and Cardiomyocytes is an endogenous counter-regulatory pathway within the RAS whose actions are opposite to the vasoconstrictor/proliferative axis of the RAS formed by ACE/Ang II/AT. receptor. In this chapter, we will briefly discuss the main findings concerning the biological role of Ang-(1-7) and its receptor Mas f沙文主义 发表于 2025-3-27 22:15:36
Kidneybtotal nephrectomy, diabetes nephropathy, adriamycin induced-nephropathy, and acute renal injury. The renoprotection of ACE2/Ang-(1-7)/Mas axis is mainly attributed to reduction of oxidative stress, inflammation, and fibrosis. Few human studies support a compensatory activation of the counter-regula许可 发表于 2025-3-28 04:09:55
Liverth. In this context, to better comprehend the role of RAS components in liver failure might pave the way for the search of potential predictive biomarkers as well as the development of novel therapeutic approaches. Valuable data have been generated from preclinical and clinical studies. Herein, we s逗它小傻瓜 发表于 2025-3-28 07:38:37
Concluding Remarksonship expected from evaluations using conventional pharmacokinetics models. Actually, as illustrated in different chapters, there are many publications showing that a single daily oral administration of the inclusion compound Ang-(1-7)/HPB-cyclodextrin is capable of producing beneficial effects inSMART 发表于 2025-3-28 13:26:20
n extensive publication record in the field, including the publication of the book .The Protective Arm of the Renin Angiotensin System .(Academic Press, 2015)..Angiotensin-(1-7) will make a unique contribution 978-3-030-22698-5978-3-030-22696-1